Prostate Cancer Awareness: What We Need to Know with Paul Arangua
6 Mar 2024 · 1 min

0:40
In this segment, Paul Arangua emphasizes the need to educate the public about prostate cancer screening and introduces how emerging genomic, germline, tissue, urine, and blood tests can enhance diagnostic accuracy for men with elevated PSA levels. He explains that these advanced biomarkers help determine whether a biopsy is necessary, allowing patients to make more informed, risk‑adapted decisions and feel greater confidence in their care pathway.










